These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10667360)

  • 1. Prostaglandin E2 as a modulator of lymphocyte mediated inflammatory and humoral responses.
    Kaur K; Harris SG; Padilla J; Graf BA; Phipps RP
    Adv Exp Med Biol; 1999; 469():409-12. PubMed ID: 10667360
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis.
    Scott P; Hondowicz B; Eaton A; Scharton-Kersten T
    Ann N Y Acad Sci; 1996 Oct; 795():250-6. PubMed ID: 8958936
    [No Abstract]   [Full Text] [Related]  

  • 3. JNK1 is required for T cell-mediated immunity against Leishmania major infection.
    Constant SL; Dong C; Yang DD; Wysk M; Davis RJ; Flavell RA
    J Immunol; 2000 Sep; 165(5):2671-6. PubMed ID: 10946297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania susceptibility puzzle gets another twist.
    Marx J
    Science; 1996 Feb; 271(5251):912-3. PubMed ID: 8584928
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.
    Titus RG; DeKrey GK; Morris RV; Soares MB
    Infect Immun; 2001 Aug; 69(8):5189-92. PubMed ID: 11447205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th2 responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses.
    Bourreau E; Gardon J; Pradinaud R; Pascalis H; Prévot-Linguet G; Kariminia A; Pascal L
    Infect Immun; 2003 Apr; 71(4):2244-6. PubMed ID: 12654849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.
    Menon JN; Bretscher PA
    Eur J Immunol; 1998 Dec; 28(12):4020-8. PubMed ID: 9862338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to Leishmania major in mice.
    Demant P; Lipoldova M; Svobodova M
    Science; 1996 Nov; 274(5291):1392-3. PubMed ID: 8966604
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.
    Sjölander A; Baldwin TM; Curtis JM; Handman E
    J Immunol; 1998 Apr; 160(8):3949-57. PubMed ID: 9558102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells: mediating compromises between host and parasite.
    Sakaguchi S
    Nat Immunol; 2003 Jan; 4(1):10-1. PubMed ID: 12496970
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-MHC-linked genetic polymorphism controls selective development of Th2 but not inhibition of Th1 cells by soluble antigen administration.
    Galbiati F; Adorini L
    Microbes Infect; 1999 Jan; 1(1):73-7. PubMed ID: 10847769
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokine-producing T cell subsets in human leishmaniasis.
    Kemp K
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):173-6. PubMed ID: 10912621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Helper 1 (Th1), Th2, and Th17 Responses to Leishmania major Lipophosphoglycan 3.
    Miahipour A; Haji-Fatahaliha M; Keshavarz H; Gharavi MJ; Mohamadi H; Babaloo Z; Rafati S; Younesi V; Hosseini M; Yousefi M
    Immunol Invest; 2016 Oct; 45(7):692-702. PubMed ID: 27611455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.
    Sato N; Ahuja SK; Quinones M; Kostecki V; Reddick RL; Melby PC; Kuziel WA; Ahuja SS
    J Exp Med; 2000 Jul; 192(2):205-18. PubMed ID: 10899907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation, regulation, and death of T helper cell subsets during infection with Leishmania major.
    Scott P
    Immunol Res; 1998; 17(1-2):229-38. PubMed ID: 9479584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.